Interleukin-6 as unfavorable prognostic factor in patients affected by Covid-19 and hip fracture

J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):353-354. doi: 10.23812/20-410-L.

Authors

A Pantalone¹, D Bruni¹, P Pantalone², R Buda¹

Affiliations

¹ Orthopaedic and Traumatology Unit, Department of Medicine and Science of Aging, University G. "d'Annunzio" of Chieti-Pescara, Chieti, Italy.
² Biodiscovery Institute and School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.

PMID: 33511825
DOI: 10.23812/20-410-L

No abstract available

Keywords: COVID-19; Interleukin-6; SARS-CoV-2; hip fracture.

Publication types

Letter

MeSH terms

COVID-19 / blood
COVID-19 / complications*
Hip Fractures / blood
Hip Fractures / complications*
Humans
Interleukin-6 / blood*
Prognosis

Substances

IL6 protein, human
Interleukin-6